Obesity, type 2 diabetes, and cancer risk

T Scully, A Ettela, D LeRoith, EJ Gallagher - Frontiers in oncology, 2021 - frontiersin.org
Obesity and type 2 diabetes have both been associated with increased cancer risk and are
becoming increasingly prevalent. Metabolic abnormalities such as insulin resistance and …

Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint

MR Islam, F Islam, MH Nafady, M Akter, S Mitra, R Das… - Molecules, 2022 - mdpi.com
Breast cancer (BrCa) is the most common malignancy in women and the second most
significant cause of death from cancer. BrCa is one of the most challenging malignancies to …

The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells

AE Baek, YRA Yu, S He, SE Wardell, CY Chang… - Nature …, 2017 - nature.com
Obesity and elevated circulating cholesterol are risk factors for breast cancer recurrence,
while the use of statins, cholesterol biosynthesis inhibitors widely used for treating …

27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology

ER Nelson, SE Wardell, JS Jasper, S Park… - Science, 2013 - science.org
Hypercholesterolemia is a risk factor for estrogen receptor (ER)–positive breast cancers and
is associated with a decreased response of tumors to endocrine therapies. Here, we show …

[HTML][HTML] Alterations in cholesterol metabolism as a risk factor for develo** Alzheimer's disease: Potential novel targets for treatment

R Loera-Valencia, J Goikolea… - The Journal of steroid …, 2019 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia and it is characterized by the
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …

Estrogenic endocrine disruptors: Molecular mechanisms of action

R Kiyama, Y Wada-Kiyama - Environment International, 2015 - Elsevier
A comprehensive summary of more than 450 estrogenic chemicals including estrogenic
endocrine disruptors is provided here to understand the complex and profound impact of …

[HTML][HTML] The role of mitochondrial dysfunction in age-related diseases

RK Lane, T Hilsabeck, SL Rea - Biochimica et Biophysica Acta (BBA) …, 2015 - Elsevier
The aging process is accompanied by the onset of disease and a general decline in
wellness. Insights into the aging process have revealed a number of cellular hallmarks of …

Cholesterol and breast cancer pathophysiology

ER Nelson, C Chang, DP McDonnell - Trends in Endocrinology & …, 2014 - cell.com
Cholesterol is a risk factor for breast cancer although the mechanisms by which this occurs
are not well understood. One hypothesis is that dyslipidemia results in increased cholesterol …

Updating the role of obesity and cholesterol in breast cancer

L Garcia-Estevez, G Moreno-Bueno - Breast Cancer Research, 2019 - Springer
Background Breast cancer is the second most common cause of cancer-related death
among women. Advances in our understanding of the disease have translated into better …

Involvement of oxysterols in age-related diseases and ageing processes

A Zarrouk, A Vejux, J Mackrill, Y O'Callaghan… - Ageing research …, 2014 - Elsevier
Ageing is accompanied by increasing vulnerability to major pathologies (atherosclerosis,
Alzheimer's disease, age-related macular degeneration, cataract, and osteoporosis) which …